Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mathias Hänel Kerstin Schäfer-Eckart Walter E Aulitzky Alexander Kiani Thomas Illmer Stefani Parmentier Norbert Frickhofen Richard Noppeney Volker Kunzmann Andreas Burchert Frank Heits Johannes Kullmer Roland Repp Ina-Maria Klut Carsten Müller-Tidow Aristoteles A N Giagounidis Johannes Schetelig Christian Thiede Stefan W. Krause Christoph Röllig Christian H Brandts Martin Bornhäuser Utz Krug Malte von Bonin Claudia D Baldus Hermann Einsele Gerhard Ehninger Markus Schaich Alwin Krämer Wolfgang E Berdel Hubert Serve |
| Publication date | November 5, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |